Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R John Collier

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
ACS Chemical Biology|February 26, 2010
A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal FactorBrad L Pentelute, Adam P Barker, Blythe E Janowiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2008
Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillusChun Kim, Sarah Wilcox-Adelman, Yasuyo Sano, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2008
Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculatureRobert E Bolcome, Sarah E Sullivan, René Zeller, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2004
Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptorD Borden Lacy, Darran J Wigelsworth, Heather M Scobie, et al.
Trends in Microbiology|June 29, 2002
2001: a year of major advances in anthrax toxin researchMichael Mourez, D Borden Lacy, Kristina Cunningham, et al.
Infection and Immunity|June 23, 2006
A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1Johanna Rivera, Antonio Nakouzi, Nareen Abboud, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
A dually active anthrax vaccine that confers protection against both bacilli and toxinsGi-Eun Rhie, Michael H Roehrl, Michael Mourez, et al.
The Journal of Biological Chemistry|September 27, 2005
Whole-cell voltage clamp measurements of anthrax toxin pore currentJoshua T Wolfe, Bryan A Krantz, G Jonah A Rainey, et al.
The Journal of Biological Chemistry|March 27, 2004
Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigenDarran J Wigelsworth, Bryan A Krantz, Kenneth A Christensen, et al.
Plos One|March 29, 2007
Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formationHeather M Scobie, John M Marlett, G Jonah A Rainey, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
ACS Chemical Biology|February 26, 2010
A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal FactorBrad L Pentelute, Adam P Barker, Blythe E Janowiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2008
Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillusChun Kim, Sarah Wilcox-Adelman, Yasuyo Sano, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2008
Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculatureRobert E Bolcome, Sarah E Sullivan, René Zeller, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2004
Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptorD Borden Lacy, Darran J Wigelsworth, Heather M Scobie, et al.
Trends in Microbiology|June 29, 2002
2001: a year of major advances in anthrax toxin researchMichael Mourez, D Borden Lacy, Kristina Cunningham, et al.
Infection and Immunity|June 23, 2006
A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1Johanna Rivera, Antonio Nakouzi, Nareen Abboud, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
A dually active anthrax vaccine that confers protection against both bacilli and toxinsGi-Eun Rhie, Michael H Roehrl, Michael Mourez, et al.
The Journal of Biological Chemistry|September 27, 2005
Whole-cell voltage clamp measurements of anthrax toxin pore currentJoshua T Wolfe, Bryan A Krantz, G Jonah A Rainey, et al.
The Journal of Biological Chemistry|March 27, 2004
Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigenDarran J Wigelsworth, Bryan A Krantz, Kenneth A Christensen, et al.
Plos One|March 29, 2007
Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formationHeather M Scobie, John M Marlett, G Jonah A Rainey, et al.
Pageof 8